Thiazolidinediones (TZDs or glitazones) are ligands of the nuclear receptor transcription factor peroxisome proliferator-activated receptor gamma (PPAR gamma) that have recently been developed as insulin sensitizers to treat patients with type 2 diabetes [55, 56]. The gene discussed is INS; the disease is type 2 diabetes mellitus.